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Intestinal pathology: Taeniasis[9] 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cerebral pathology: Neurocysticercosis 
 
Larvae suffer some pathological changes until its death. This evolution can 
be described in four stages: 
 
    1.Vesicular stage 
    2.Colloidal vesicular stage 
    3.Granular nodular stage 
    4.Calcified nodular stage 
 
These pathology is characterized by a natural progression of innate 
(neutrophils and macrophages), early induced (NK cells and γδ T cells) and 
adaptive immune response (αβ T cells and B cells) in infected mice.Th1 
response 
 
 
 
 
 
 
It depends on the number, size, stage and localization of cysts and the 
patient’s immune response.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Possible explanation of relation between brain injury, inflammation and 
epilepsy [6] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General information: 
 
 
 
 
 
 
 
 
 
Taenia solium:  
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immunity 
Dichotomous role 
of inflammation 
Infection Seizures Unknown 
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Affected countries: Latin America,  India, Asia and Sub-Saharan Africa. 
Imported cases: Europe, Australia, USA and Canada. 
                        1/1000 for human teaniasis 
 Incidence    1-10% for humans CC  
                        20-40% for pig CC 
Age of infection: 5-15 years old 
Age of manifestation: 25-35 years old 
Problems: high poverty, warm weather, illiteracy... 
  
   Immunodiagnosis                                                                        Medical imaging  
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Lifecycle of Taenia solium 
 
• Neurocysticercosis is  endemic in many parts of the world, specially in developing countries. However we have 
to take into consideration the diagnosis in developed countries by immigration of endemic countries. 
 
•Neurocysticercosis is the most common cause of symptomatic epilepsy worldwide. Despite the severity of the 
disease, most people don’t give the importance to it, since it principally affects developing countries. 
 
•Treatment and diagnosis works well, but can be improved. 
 
•This parasitic disease is potentially eradicable, but to be effective we need eradication programs that consists: 
  
     1. Interrupt the tape worm-host cycle. 
     2. The vaccination of pig against infection with the parasite, which indirectly reduce the appearance of new  
         cases of the disease. 
     3. Public health and awareness. 
     4. Possible vaccination for human. 
 
But the best alternative is the education and the health promotion, specially in developing countries. 
 
 
                              
                    Taenia solium                                              Cerebral symptoms                                               Surgery 
 
 
 
                                                                           
         Albendazol                      Praziquantel                      Epilepsy                                              Inflammation                                                           
 
 
 
 
 
                  
•Dose: 50 mg/kg/day 
•Duration: 15 days 
•Efficacy: 60-70% in  
  parenchymatous cyst 
 
•Dose: 15 mg/kg/day 
•Duration: 3 weeks 
•Efficacy: 80% of the cyst 
 
•Enhance GABA channel (fenobarbiturate     
  and benzodiazepine) 
•Inhibit Sodium channel (carbamazepine) 
•Inhibit Calcium channel (gabapentin) 
 
•Corticosteroid: Prednisolone 
 
8.Conclusions 7.Treatment 
4.Diagnosis 
 
Clinical manifestation [5] 
 
Pathology 
 
Epilepsy 
 
Pericyst inflammation, granuloma formation 
 
Raised intracranial pressure 
 
Hydrocephalus (arachnoiditis, ependymitis, ventricular 
cysts), pseudotumor (edema), giant cysts, cysticercal 
encephalitis 
 
Focal deficits 
 
Direct compression by large or multiple cysts 
 
Meningitis 
 
Widespreas subarachnoid inflammation 
 
Myelo radiculopathy 
 
Inlammation, local mass effect, vasculitis 
 
Others 
 
Dementia 
 
Multiple parenchymatous cysts 
 
Encephalitis 
 
Intense inflammation and edema 
 
Subarachnoid haemorrhage 
 
Inflammatory aneurysm 
 
Trigeminal neuralgia 
 
Arachnoiditis 
 
Subdual hematoma 
 
Collection of multiple cysts 
 
Stroke/transient ischemia attack 
 
Angiitis 
 
Dizziness 
 
Intermittent CSF obstruction 
 
Endocrinological or ophthalmic symptoms 
 
Sellar/intraocular cysts 
1.Diagnostic criteria [3] 
Absolute criteria 
• Histologic demonstration of the parasite from biopsy of a brain 
or spinal cord lesion 
•Cystic lesions showing the scolex on CT or MRI 
•Direct visualization of subretinal parasites by funduscopic 
examination 
Major criteria 
•Lesions highly suggestive of neurocysticercosis on neuroimaging 
 studies 
•Positive serum EITB for the detection of anticysticercal antibodies 
•Resolution of intracranial cystic lesions after therapy with 
albendazole or praziquantel 
•Spontaneous resolution of small single enhancing lesions 
Minor criteria 
• Lesions compatible with neurocysticercosis on neuroimaging 
studies 
• Clinical manifestations suggestive of neurocysticercosis 
•Positive CSF ELISA for detection of anticysticercal antibodies or 
cysticercal antigens 
•Cysticercosis outside the CNS 
Epidemiologic criteria 
•Evidence of a household contact with Taenia solium infection 
•Individuals coming from or living in an area where cysticercosis 
is endemic 
•History of frequent travel to disease-endemic areas 
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Activation  and differentiation 
of naive CD4 T cells in the 
presence of IL-4 into Th 2 cells. 
Taenia solium cause 
the synthesis and 
secretion of IL-4 by 
NK T cells 
Is a cestode that belongs to the Cyclophyllidea order and the Taeniidae family. 
Tree Stage: egg, larvae and adult tapeworm. 
Target tissues: CNS, eye, skeletal and heart muscles, subcutaneous tissues. 
 
 
Brain parenchyma 
Time p.i IL-2 IL-12 INF-γ TNF-α IL-5 Il-1,6,13 Il-4,10 
2 days - - - ND - - - 
3 days - - - ND - - - 
5 days - - - ND - - - 
1 wk - - - - - - - 
3 wk - + - - - - - 
5 wk - + + - + - - 
8 wk - + + - - - - 
11 wk + + - - - - - 
13 wk + + - - - - - 
Cytokines were detected in immunohistochemistry reaction.-, undetectable;+, 1-100 positive cells 
per section; ++, 100-300 positive cells; +++, 300-500 positive cells;++++, >500 positive cells. MHC 
class II expression=I-Ad.[4] 
Possible causes of epilepsy: 
 
Cytokines: IL-1β, IL-6 and TNFα 
 Permeability of blood–brain barrier 
Gliosis 
Neuronal death 
ELISA results using HISTS14 antigen. In (A) serum sample 
from patients and in (B) CFS sample.[2] 
Left: RMN showing one cyst. Right: TAC showing 
multiple parenchymal brain calcification.[5, 10] 
2. Degrees of certainty for the diagnosis [3] 
Definitive diagnosis 
• Presence of one absolute criterion 
•Presence of two major plus one minor and one epidemiologic criterion 
Probable diagnosis 
•Presence of one major plus two minor criteria 
•Presence of one major plus one minor and one epidemiologic criterion 
•Presence of three minor plus one epidemiologic criterion 
Diagnostic criteria  
Map illustrates the distribution of Neurocysticercosis.[1] 
3.Introduction 
1. Objective 
 
Neuroinfections are important brain diseases and they affect a lot of people all over the world, but not all the people know 
about their existence. The aim of this work is to deepen in the pathological, biochemistry and clinical aspects of  
Neurocysticercosis, an helminthic disease that affects the central nervous system. It is caused by larvae of Taenia solium, 
who lives in the small intestine of humans. 
2.Sources and methods 
Sources 
Articles, books and scientific reviews about Neurocysticercosis. 
 
Methods 
•Search all the information. 
•Read general articles about the topic to get a general idea, and then more specifics articles. 
•Sum up all the important aspects of the pathology. 
 
5.Immuno response 6.Clinical Manifestations 
1.Adult Taenia 
solium in small 
intestine 
2.Taenia solium eggs in 
human feces  
3.Taenia solium eggs 
ingested by pork 
4.Cysticerci in 
pork muscles 
5.Infected pork meat 
ingested by humans  
6.Larvae evagination 
in human stomach 
9.Neurocysticercosis 
8.Taenia solium eggs 
ingested by humans 
7.Auto contamination 
   Contaminated water 
   Contaminated food 
Body (proglottids)  Neck Scolex 
Subcutaneous 
tissues 
CNS 
Eyes 
Muscles 
Taenia solium 
Places affected 
Larvae 
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